Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PIGN encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. Additionally we are shipping Phosphatidylinositol Glycan Anchor Biosynthesis, Class N Antibodies (20) and Phosphatidylinositol Glycan Anchor Biosynthesis, Class N Proteins (4) and many more products for this protein.
PIGN mutation is associated with multiple congenital anomalies hypotonia seizures syndrome related epilepsy.
The mutated PIGN caused a significant decrease of the overall glycosylphoshatidylinositol-anchored proteins and CD24 (show CD24 ELISA Kits) expression which is sufficient to cause severe phenotypic expression.
Findings confirm that developmental delay, hypotonia, and epilepsy combined with congenital anomalies are common phenotypes of PIGN mutations and add progressive cerebellar atrophy to this clinical spectrum.
PIGN encodes phosphatidylinositol-glycan biosynthesis class N protein.
Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN.
This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported.
, GPI ethanolamine phosphate transferase 1
, MCD4 homolog
, phosphatidylinositol-glycan biosynthesis class N protein
, phosphatidylinositol glycan, class N